Sign in

CIK 0001553643

  • Non-accelerated filer
  • Smaller reporting company

RELMADA THERAPEUTICS, INC.

Sign in to watch
Ticker
RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
455401931
Phone
+1 646-876-3459
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Former names
CAMP NINE, INC.
  1. 4 Open-market buy Director bought 3,000 shares at an average $2.99 ($8,958)
  2. 4 Open-market buy Chief Executive Officer bought 18,970 shares at an average $3.05 ($57,792)
  3. 4 Open-market buy Director bought 1,100 shares at an average $3.43 ($3,775)
  4. 4 Open-market buy Director bought 10,500 shares at an average $2.93 ($30,728)
  5. 4 Open-market buy Director bought 10,000 shares at an average $2.91 ($29,055)
  6. 4 Open-market buy Chief Executive Officer bought 30 shares at $2.97 ($89)
  7. 4 Open-market buy Director bought 2,000 shares at $2.89 ($5,780)
  8. 4 Open-market buy Director bought 4,200 shares at an average $2.97 ($12,464)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 10 of 10 · 200 filings